Richard Garand

5.9k total citations
80 papers, 3.2k citations indexed

About

Richard Garand is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Richard Garand has authored 80 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 41 papers in Genetics and 23 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Richard Garand's work include Chronic Lymphocytic Leukemia Research (34 papers), Acute Myeloid Leukemia Research (34 papers) and Acute Lymphoblastic Leukemia research (23 papers). Richard Garand is often cited by papers focused on Chronic Lymphocytic Leukemia Research (34 papers), Acute Myeloid Leukemia Research (34 papers) and Acute Lymphoblastic Leukemia research (23 papers). Richard Garand collaborates with scholars based in France, Canada and United Kingdom. Richard Garand's co-authors include Hervé Avet‐Loiseau, Régis Bataille, Nelly Robillard, Jean‐Luc Harousseau, Philippe Moreau, Pascaline Talmant, Marc‐Henri Stern, Jean Soulier, François Sigaux and Nöel Milpied and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Richard Garand

80 papers receiving 3.1k citations

Peers

Richard Garand
J. W. Vardiman United States
Paula Marlton Australia
John Swansbury United Kingdom
Ricardo Morilla United Kingdom
Debra M. Lillington United Kingdom
J. W. Vardiman United States
Richard Garand
Citations per year, relative to Richard Garand Richard Garand (= 1×) peers J. W. Vardiman

Countries citing papers authored by Richard Garand

Since Specialization
Citations

This map shows the geographic impact of Richard Garand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Garand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Garand more than expected).

Fields of papers citing papers by Richard Garand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Garand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Garand. The network helps show where Richard Garand may publish in the future.

Co-authorship network of co-authors of Richard Garand

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Garand. A scholar is included among the top collaborators of Richard Garand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Garand. Richard Garand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mullier, François, Sylvie Daliphard, Richard Garand, et al.. (2011). Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study. Annals of Hematology. 91(2). 203–213. 10 indexed citations
2.
Clemenceau, Béatrice, Régine Vivien, Nelly Robillard, et al.. (2008). Effector Memory αβ T Lymphocytes Can Express FcγRIIIa and Mediate Antibody-Dependent Cellular Cytotoxicity. The Journal of Immunology. 180(8). 5327–5334. 48 indexed citations
3.
Chevallier, Patrice, Mathilde Hunault, Fabrice Larosa, et al.. (2008). A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial. Leukemia Research. 33(8). 1124–1126. 12 indexed citations
4.
Chevallier, Patrice, Beatrice Mahé, Richard Garand, et al.. (2008). Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression. International Journal of Hematology. 88(2). 209–211. 9 indexed citations
5.
Chaigne-Delalande, Benjamin, Edith Reuzeau, Christine Varon, et al.. (2006). RhoGTPases and p53 Are Involved in the Morphological Appearance and Interferon-α Response of Hairy Cells. American Journal Of Pathology. 168(2). 562–573. 18 indexed citations
6.
Asnafi, Vahid, Kheïra Beldjord, Richard Garand, et al.. (2004). IgH DJ rearrangements within T-ALL correlate with cCD79a expression, an immature/TCRγδ phenotype and absence of IL7Rα/CD127 expression. Leukemia. 18(12). 1997–2001. 8 indexed citations
7.
Avet‐Loiseau, Hervé, Richard Garand, Laurence Lodé, Nelly Robillard, & Régis Bataille. (2003). 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia. Seminars in Oncology. 30(2). 153–155. 43 indexed citations
8.
Casasnovas, Olivier, Richard Garand, Lydia Campos, et al.. (2003). Immunological classification of acute myeloblastic leukemias: relevance to patient outcome. Leukemia. 17(3). 515–527. 65 indexed citations
9.
Duchayne, Éliane, Odile Fenneteau, Marie‐Pierre Pagès, et al.. (2002). Acute Megakaryoblastic Leukaemia: A National Clinical and Biological Study of 53 Adult and Childhood Cases by the Groupe Français d'Hématologie Cellulaire (GFHC). Leukemia & lymphoma. 44(1). 49–58. 41 indexed citations
10.
Robain, Mathieu, Frédéric Davi, Richard Garand, et al.. (2001). A Multicentric Study of 41 Cases of B-Prolymphocytic Leukemia: Two Evolutive Forms: The Groupe Français d'Hématologie Cellulaire. Leukemia & lymphoma. 42(5). 981–987. 25 indexed citations
11.
Garand, Richard, Surinder S. Sahota, Hervé Avet‐Loiseau, et al.. (2000). IgG‐secreting lymphoplasmacytoid leukaemia: a B‐cell disorder with extensively mutated VH genes undergoing Ig isotype‐switching frequently associated with trisomy 12. British Journal of Haematology. 109(1). 71–80. 11 indexed citations
12.
Mossafa, Hossein, Marc Maynadié, Françoise Valensi, et al.. (1999). Persistent polyclonal B lymphocytosis with binucleated lymphocytes: a study of 25 cases. British Journal of Haematology. 104(3). 486–493. 33 indexed citations
13.
Hamidou, M., et al.. (1999). Localisation neuroméningée d'un syndrome de Richter. La Revue de Médecine Interne. 20(1). 64–67. 6 indexed citations
14.
Garand, Richard, André Brizard, Jacqueline Buisine, et al.. (1998). Indolent course as a relatively frequent presentation in T‐prolymphocytic leukaemia. British Journal of Haematology. 103(2). 488–494. 95 indexed citations
15.
Talmant, Pascaline, Françoise Méchinaud, Richard Garand, et al.. (1997). Comparative genomic hybridization is a powerful tool, complementary to cytogenetics, to identify chromosomal abnormalities in childhood acute lymphoblastic leukaemia. British Journal of Haematology. 99(3). 589–596. 21 indexed citations
16.
17.
Talmant, Pascaline, et al.. (1996). Childhood B-cell acute lymphoblastic leukemia with FAB-L1 morphology and a t(9;11) translocation involving the MLL gene. PubMed. 38(3). 265–268. 8 indexed citations
18.
Béné, Marie C., et al.. (1995). Expression and Long-Term Prognostic Value of CD34 in Childhood and Adult Acute Lymphoblastic Leukemia. Leukemia & lymphoma. 20(1-2). 137–142. 11 indexed citations
19.
Garand, Richard, et al.. (1993). Incidence, Clinical and Laboratory Features, and Prognostic Significance of Immunophenotypic Subgroups in Acute Lymphoblastic Leukemia: The GEIL Experience. Recent results in cancer research. 131. 283–295. 12 indexed citations
20.
Goasguen, J., et al.. (1990). Prognostic factors of myelodysplastic syndromes—A simplified 3-D scoring system. Leukemia Research. 14(3). 255–262. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026